HOTCHKIS & WILEY's JAZZ Position Overview
HOTCHKIS & WILEY (via Hotchkis & Wiley Capital Management LLC) currently holds 118,982 shares of Jazz Pharmaceuticals plc (JAZZ) worth $20.23 M, representing 0.06% of the portfolio. First purchased in 2021-Q3, this medium-term investment has been held for 18 quarters.
Based on 13F filings, HOTCHKIS & WILEY has maintained a strategic position in JAZZ, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 108,349 shares. Largest reduction occurred in Q4 2025, reducing 19,127 shares.
Analysis based on 13F filings available since 2013 Q2
HOTCHKIS & WILEY's Jazz Pharmaceuticals plc (JAZZ) Holding Value Over Time
Track share changes against reported price movement
Quarterly Jazz Pharmaceuticals plc (JAZZ) Trades by HOTCHKIS & WILEY
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -19,127 | Reduce 13.85% | 118,982 | $170.00 |
| Q3 2025 | +108,349 | Add 364.08% | 138,109 | $131.80 |
| Q2 2025 | +20 | Add 0.07% | 29,760 | $106.12 |
| Q1 2025 | -11,775 | Reduce 28.36% | 29,740 | $124.15 |
| Q4 2024 | -5 | Reduce 0.01% | 41,515 | $123.15 |
| Q3 2024 | +75 | Add 0.18% | 41,520 | $111.41 |
| Q2 2024 | +10 | Add 0.02% | 41,445 | $106.73 |
| Q1 2024 | +21,600 | Add 108.90% | 41,435 | $120.42 |
| Q4 2023 | +3,800 | Add 23.70% | 19,835 | $123.00 |
| Q3 2023 | -50 | Reduce 0.31% | 16,035 | $129.44 |
| Q2 2023 | +20 | Add 0.12% | 16,085 | $123.97 |
| Q4 2022 | +65 | Add 0.41% | 16,065 | $159.31 |
| Q2 2022 | -18,700 | Reduce 53.89% | 16,000 | $156.00 |
| Q1 2022 | +300 | Add 0.87% | 34,700 | $155.68 |
| Q4 2021 | -500 | Reduce 1.43% | 34,400 | $127.41 |
| Q3 2021 | +34,900 | New Buy | 34,900 | $130.20 |
HOTCHKIS & WILEY's Jazz Pharmaceuticals plc Investment FAQs
HOTCHKIS & WILEY first purchased Jazz Pharmaceuticals plc (JAZZ) in Q3 2021, acquiring 34,900 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
HOTCHKIS & WILEY has held Jazz Pharmaceuticals plc (JAZZ) for 18 quarters since Q3 2021.
HOTCHKIS & WILEY's largest addition to Jazz Pharmaceuticals plc (JAZZ) was in Q3 2025, adding 138,109 shares worth $18.2 M.
According to the latest 13F filing for Q4 2025, HOTCHKIS & WILEY's firm, Hotchkis & Wiley Capital Management LLC, owns 118,982 shares of Jazz Pharmaceuticals plc (JAZZ), valued at approximately $20.23 M.
As of the Q4 2025 filing, Jazz Pharmaceuticals plc (JAZZ) represents approximately 0.06% of HOTCHKIS & WILEY's publicly disclosed stock portfolio, making it one of their key holdings.
HOTCHKIS & WILEY's peak holding in Jazz Pharmaceuticals plc (JAZZ) was 138,109 shares, as reported at the end of Q3 2025.